List of Excipients in API cladribine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cladribine
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
EMD Serono Inc | MAVENCLAD | cladribine | 44087-4000 | HYDROXYPROPYL BETADEX | |
EMD Serono Inc | MAVENCLAD | cladribine | 44087-4000 | MAGNESIUM STEARATE | |
EMD Serono Inc | MAVENCLAD | cladribine | 44087-4000 | SORBITOL | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing cladribine
Detailed excipient profiles for cladribine
Excipient focus: HYDROXYPROPYL BETADEX
cladribine drug variants containing HYDROXYPROPYL BETADEX
Company | Ingredient | NDC |
---|---|---|
EMD Serono Inc | cladribine | 44087-4000 |
>Company | >Ingredient | >NDC |
cladribine drug variants not containing HYDROXYPROPYL BETADEX
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cladribine | 0143-9871 |
Hisun Pharmaceuticals USA Inc | cladribine | 42658-010 |
Fresenius Kabi USA LLC | cladribine | 63323-140 |
Mylan Institutional LLC | cladribine | 67457-450 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
cladribine drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
EMD Serono Inc | cladribine | 44087-4000 |
>Company | >Ingredient | >NDC |
cladribine drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cladribine | 0143-9871 |
Hisun Pharmaceuticals USA Inc | cladribine | 42658-010 |
Fresenius Kabi USA LLC | cladribine | 63323-140 |
Mylan Institutional LLC | cladribine | 67457-450 |
>Company | >Ingredient | >NDC |
Excipient focus: PHOSPHORIC ACID
cladribine drug variants containing PHOSPHORIC ACID
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cladribine | 0143-9871 |
Hisun Pharmaceuticals USA Inc | cladribine | 42658-010 |
Fresenius Kabi USA LLC | cladribine | 63323-140 |
Mylan Institutional LLC | cladribine | 67457-450 |
>Company | >Ingredient | >NDC |
cladribine drug variants not containing PHOSPHORIC ACID
Company | Ingredient | NDC |
---|---|---|
EMD Serono Inc | cladribine | 44087-4000 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
cladribine drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cladribine | 0143-9871 |
Hisun Pharmaceuticals USA Inc | cladribine | 42658-010 |
Fresenius Kabi USA LLC | cladribine | 63323-140 |
Mylan Institutional LLC | cladribine | 67457-450 |
>Company | >Ingredient | >NDC |
cladribine drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
EMD Serono Inc | cladribine | 44087-4000 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE
cladribine drug variants containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hisun Pharmaceuticals USA Inc | cladribine | 42658-010 |
>Company | >Ingredient | >NDC |
cladribine drug variants not containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cladribine | 0143-9871 |
EMD Serono Inc | cladribine | 44087-4000 |
Fresenius Kabi USA LLC | cladribine | 63323-140 |
Mylan Institutional LLC | cladribine | 67457-450 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
cladribine drug variants containing SODIUM PHOSPHATE, DIBASIC
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cladribine | 0143-9871 |
Fresenius Kabi USA LLC | cladribine | 63323-140 |
Mylan Institutional LLC | cladribine | 67457-450 |
>Company | >Ingredient | >NDC |
cladribine drug variants not containing SODIUM PHOSPHATE, DIBASIC
Company | Ingredient | NDC |
---|---|---|
Hisun Pharmaceuticals USA Inc | cladribine | 42658-010 |
EMD Serono Inc | cladribine | 44087-4000 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
cladribine drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
EMD Serono Inc | cladribine | 44087-4000 |
>Company | >Ingredient | >NDC |
cladribine drug variants not containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cladribine | 0143-9871 |
Hisun Pharmaceuticals USA Inc | cladribine | 42658-010 |
Fresenius Kabi USA LLC | cladribine | 63323-140 |
Mylan Institutional LLC | cladribine | 67457-450 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
cladribine drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Hisun Pharmaceuticals USA Inc | cladribine | 42658-010 |
>Company | >Ingredient | >NDC |
cladribine drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cladribine | 0143-9871 |
EMD Serono Inc | cladribine | 44087-4000 |
Fresenius Kabi USA LLC | cladribine | 63323-140 |
Mylan Institutional LLC | cladribine | 67457-450 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.